Literature DB >> 21318450

Fasting FDG PET compared to MPI SPECT in cardiac sarcoidosis.

Scott C Brancato1, James A Arrighi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21318450     DOI: 10.1007/s12350-011-9347-2

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  13 in total

1.  Technetium-99m sestamibi/tetrofosmin myocardial perfusion scanning in cardiac and noncardiac sarcoidosis.

Authors:  M Eguchi; K Tsuchihashi; D Hotta; A Hashimoto; H Sasao; S Yuda; T Nakata; N Shijubou; S Abe; K Shimamoto
Journal:  Cardiology       Date:  2000       Impact factor: 1.869

2.  Scintigraphic demonstration of myocardial sarcoidosis: the added value of single-photon emission computed tomography.

Authors:  P C Barneveld; C van Leeuwen; J W van Isselt
Journal:  J Nucl Cardiol       Date:  1997 May-Jun       Impact factor: 5.952

3.  Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis.

Authors:  Shinji Ishimaru; Ichizo Tsujino; Toshiki Takei; Eriko Tsukamoto; Shinji Sakaue; Mitsunori Kamigaki; Naofumi Ito; Hiroshi Ohira; Daisuke Ikeda; Nagara Tamaki; Masaharu Nishimura
Journal:  Eur Heart J       Date:  2005-04-04       Impact factor: 29.983

4.  Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis.

Authors:  Wataru Okumura; Tsutomu Iwasaki; Takuji Toyama; Tatsuya Iso; Masashi Arai; Noboru Oriuchi; Keigo Endo; Tomoyuki Yokoyama; Tadashi Suzuki; Masahiko Kurabayashi
Journal:  J Nucl Med       Date:  2004-12       Impact factor: 10.057

5.  The utility of delayed-enhancement magnetic resonance imaging for identifying nonischemic myocardial fibrosis in asymptomatic patients with biopsy-proven systemic sarcoidosis.

Authors:  B Y C Cheong; R Muthupillai; M Nemeth; B Lambert; D Dees; S Huber; R Castriotta; S D Flamm
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2009-07       Impact factor: 0.670

Review 6.  Cardiac sarcoidosis.

Authors:  Jessica S Kim; Marc A Judson; Robert Donnino; Michael Gold; Leslie T Cooper; Eric N Prystowsky; Stephen Prystowsky
Journal:  Am Heart J       Date:  2008-11-12       Impact factor: 4.749

7.  Cardiac involvement in patients with sarcoidosis: diagnostic and prognostic value of outpatient testing.

Authors:  Davendra Mehta; Steven A Lubitz; Zev Frankel; Juan P Wisnivesky; Andrew J Einstein; Martin Goldman; Josef Machac; Alvin Teirstein
Journal:  Chest       Date:  2008-03-13       Impact factor: 9.410

8.  Myocardial sarcoidosis. Clinical value of technetium-99m sestamibi tomoscintigraphy.

Authors:  D Le Guludec; F Menad; M Faraggi; P Weinmann; J P Battesti; D Valeyre
Journal:  Chest       Date:  1994-12       Impact factor: 9.410

9.  Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis.

Authors:  Hiroshi Ohira; Ichizo Tsujino; Shinji Ishimaru; Noriko Oyama; Toshiki Takei; Eriko Tsukamoto; Masatake Miura; Shinji Sakaue; Nagara Tamaki; Masaharu Nishimura
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-12-15       Impact factor: 9.236

10.  Cardiac sarcoidosis: reversion of myocardial perfusion abnormalities by dipyridamole.

Authors:  P Tellier; D Valeyre; A Nitenberg; J M Foult; G Bedig; J P Battesti
Journal:  Eur J Nucl Med       Date:  1985
View more
  2 in total

Review 1.  Radionuclide Imaging Applications in Cardiomyopathies and Heart Failure.

Authors:  Matthew E Harinstein; Prem Soman
Journal:  Curr Cardiol Rep       Date:  2016-03       Impact factor: 2.931

Review 2.  The use of (18)F-FDG-PET/CT for diagnosis and treatment monitoring of inflammatory and infectious diseases.

Authors:  Andor W J M Glaudemans; Erik F J de Vries; Filippo Galli; Rudi A J O Dierckx; Riemer H J A Slart; Alberto Signore
Journal:  Clin Dev Immunol       Date:  2013-08-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.